Roche, which already owns 56% of Genentech, just offered to buy the rest of the company for about $43.7 billion, the WSJ reports.
The offer of $89 per share in cash represents an 8.8% premium to where the stock closed on Friday, and a 19% premium to where the stock closed a month ago. At a [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment